Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEAReshma Jagsi, Mahmoud El‐Tamer, Alphonse G. Taghian et al.|Journal of Clinical Oncology|2023Cited by 100
Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategyJoseph M. Herman, Howard M. Sandler, David C. Smith et al.|Urology|2004Cited by 37
Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with<sup>131</sup>I-tositumomabRebecca Elstrom, Mark Kaminski, Jia Ruan et al.|Leukemia & lymphoma/Leukemia and lymphoma|2014Cited by 14
Planned Interim Analysis Results from a Prospective Multicenter Single-Arm Cohort Study of Patients Receiving Endocrine Therapy but Not Radiotherapy after Breast-Conserving Surgery for Early-Stage Breast Cancer with Favorable Biologic FeaturesReshma Jagsi, Mahmoud El‐Tamer, Kent A. Griffith et al.|International Journal of Radiation Oncology*Biology*Physics|2019Cited by 6
Reply to G.B. Mann et al and S. SorscherReshma Jagsi, Mahmoud El‐Tamer, Kent A. Griffith et al.|Journal of Clinical Oncology|2024Cited by 1